Dr. Kerry Rogers is physician scientist at the Ohio State University James Cancer Hospital specializing in the treatment of chronic lymphocytic leukemia (CLL) and hairy cell leukemia. In addition being a practicing hematologist taking care of patients with CLL and hairy cell leukemia, she leads clinical trials studying new treatments for these leukemias and does translational laboratory research. One of her major focuses is improving the use of BTK inhibitors by using combination treatments that avoid traditional chemotherapy. She is an Assistant Professor in the Division of Hematology at The Ohio State University.